Literature DB >> 19276402

Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage.

Yueming Tang1, Christopher B Forsyth, Ali Banan, Jeremy Z Fields, Ali Keshavarzian.   

Abstract

We reported previously that oats supplementation prevents gut leakiness and alcoholic steatohepatitis (ASH) in our rat model of alcoholic liver disease. Because oxidative stress is implicated in the pathogenesis of both alcohol-induced gut leakiness and ASH, and because oats have antioxidant properties, we tested the hypothesis that oats protect by preventing alcohol-induced oxidative damage to the intestine. Male Sprague-Dawley rats were gavaged for 12 weeks with alcohol (starting dose of 1 g/kg increasing to 6 g/kg/day over the first 2 weeks) or dextrose, with or without oats supplementation (10 g/kg/day). Oxidative stress and injury were assessed by measuring colonic mucosal inducible nitric-oxide synthase (iNOS) (by immunohistochemistry), nitric oxide (colorimetric assay), and protein carbonylation and nitrotyrosination (immunoblotting). Colonic barrier integrity was determined by assessing the integrity of the actin cytoskeleton (immunohistochemistry) and the integrity of tight junctions (electron microscopy). Oats supplementation prevented alcohol-induced up-regulation of iNOS, nitric oxide overproduction in the colonic mucosa, and increases in protein carbonyl and nitrotyrosine levels. This protection was associated with prevention of ethanol (EtOH)-induced disorganization of the actin cytoskeleton and disruption of tight junctions. We conclude that oats supplementation attenuates EtOH-induced disruption of intestinal barrier integrity, at least in part, by inhibiting EtOH-induced increases in oxidative stress and oxidative tissue damage. This inhibition prevents alcohol-induced disruption of the cytoskeleton and tight junctions. This study suggests that oats may be a useful therapeutic agent--a nutraceutical--for the prevention of alcohol-induced oxidative stress and organ dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276402      PMCID: PMC2683774          DOI: 10.1124/jpet.108.148643

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

1.  Alcohol: "ice-breaker" yes, "gut barrier-breaker," maybe.

Authors:  A Keshavarzian; J Fields
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

Review 2.  Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Authors:  Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

Review 3.  Review article: alcoholic liver disease--pathophysiological aspects and risk factors.

Authors:  A Gramenzi; F Caputo; M Biselli; F Kuria; E Loggi; P Andreone; M Bernardi
Journal:  Aliment Pharmacol Ther       Date:  2006-10-15       Impact factor: 8.171

4.  Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production.

Authors:  Lin Nie; Mitchell L Wise; David M Peterson; Mohsen Meydani
Journal:  Atherosclerosis       Date:  2005-09-01       Impact factor: 5.162

5.  Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms.

Authors:  A Banan; S Choudhary; Y Zhang; J Z Fields; A Keshavarzian
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

6.  Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease.

Authors:  Yueming Tang; Ali Banan; Christopher B Forsyth; Jeremy Z Fields; Cynthia K Lau; Li Juan Zhang; Ali Keshavarzian
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

7.  Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage.

Authors:  Yueming Tang; Christopher B Forsyth; Ashkan Farhadi; Jayanthi Rangan; Shriram Jakate; Maliha Shaikh; Ali Banan; Jeremy Z Fields; Ali Keshavarzian
Journal:  Alcohol Clin Exp Res       Date:  2009-04-09       Impact factor: 3.455

Review 8.  Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.

Authors:  Kiyoshi Nagata; Hiroyuki Suzuki; Shuhei Sakaguchi
Journal:  J Toxicol Sci       Date:  2007-12       Impact factor: 2.196

9.  Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats.

Authors:  Ali Keshavarzian; Ashkan Farhadi; Christopher B Forsyth; Jayanthi Rangan; Shriram Jakate; Maliha Shaikh; Ali Banan; Jeremy Z Fields
Journal:  J Hepatol       Date:  2008-12-29       Impact factor: 25.083

10.  NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium.

Authors:  A Banan; A Keshavarzian; L Zhang; M Shaikh; C B Forsyth; Y Tang; J Z Fields
Journal:  Alcohol       Date:  2007-09-14       Impact factor: 2.405

View more
  27 in total

1.  Assessment of the Effects of 6 Standard Rodent Diets on Binge-Like and Voluntary Ethanol Consumption in Male C57BL/6J Mice.

Authors:  Simon Alex Marshall; Jennifer A Rinker; Langston K Harrison; Craig A Fletcher; Tina M Herfel; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

Review 2.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

3.  Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats.

Authors:  Wei Zhong; Qiong Li; Guoxiang Xie; Xiuhua Sun; Xiaobing Tan; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-10       Impact factor: 4.052

Review 4.  Microbiota-based treatments in alcoholic liver disease.

Authors:  Hotaik Sung; Seung Woo Kim; Meegun Hong; Ki Tae Suk
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 5.  A biological framework for emotional dysregulation in alcohol misuse: from gut to brain.

Authors:  Carina Carbia; Séverine Lannoy; Pierre Maurage; Eduardo López-Caneda; Kenneth J O'Riordan; Timothy G Dinan; John F Cryan
Journal:  Mol Psychiatry       Date:  2020-12-07       Impact factor: 15.992

6.  Is moderate red wine consumption safe in inactive inflammatory bowel disease?

Authors:  Garth R Swanson; Vanessa Tieu; Maliha Shaikh; Chris Forsyth; Ali Keshavarzian
Journal:  Digestion       Date:  2011-08-26       Impact factor: 3.216

7.  The Role of miR-212 and iNOS in Alcohol-Induced Intestinal Barrier Dysfunction and Steatohepatitis.

Authors:  Yueming Tang; Lijuan Zhang; Christopher B Forsyth; Maliha Shaikh; Shiwen Song; Ali Keshavarzian
Journal:  Alcohol Clin Exp Res       Date:  2015-07-24       Impact factor: 3.455

8.  Tributyrin supplementation protects mice from acute ethanol-induced gut injury.

Authors:  Gail A Cresci; Katelyn Bush; Laura E Nagy
Journal:  Alcohol Clin Exp Res       Date:  2014-05-30       Impact factor: 3.455

9.  Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease.

Authors:  Arthur W Yan; Bernd Schnabl
Journal:  World J Hepatol       Date:  2012-04-27

Review 10.  MicroRNAs: master regulators of ethanol abuse and toxicity?

Authors:  Rajesh C Miranda; Andrzej Z Pietrzykowski; Yueming Tang; Pratheesh Sathyan; Dayne Mayfield; Ali Keshavarzian; Wayne Sampson; Dale Hereld
Journal:  Alcohol Clin Exp Res       Date:  2010-01-26       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.